Prognosis and Prognostic Factors of Serous Borderline Tumor-Micropapillary Variant: Retrospective Study of 200 Patients with Long-Term Follow-Up.

J Oncol · 2022 · PMC9576405 · PMID 36262351

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Further supporting data were from the national Denmark cohort involving 80 SBOT-Ms (in whom 58 stage I); patients with advanced stage showed a trend toward increasing risk of developing serous carcinoma, although not statistical significance (HR = 2.6; 95% CI: 0.6–10.5; stage II-III versus I) [ 19 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.